4.4.9.3Vertical
Chronic Disease Management
Companies delivering disease management programs for at-risk patients.
Market snapshot
These figures describe Population Health Management (4.4.9), the segment that Chronic Disease Management sits within. They are not figures for Chronic Disease Management on its own.
FragmentationConsolidatingEstimate
No discrete Census NAICS code. Population-health and VBC enablement sit within healthcare-services and technology classifications, so the segment is not separately sized by the Census Bureau.
Business model & economics
Revenue model
Shared-savings, capitation, and enablement fees
Key economics
- Recurring revenue
- High
- EBITDA margin
- Risk- and execution-dependent
- Capex intensity
- Low
risk-bearing and platform contracts
Characteristics
- Central to the fee-for-service-to-value-based shift.
- Medicare Advantage and ACO programs drive growth.
- Risk-bearing economics and analytics define the model.
M&A deal context
Deal activityHigh
Who’s acquiring
- Value-based-care enablement platforms
- Payer & provider strategics
- PE- and VC-backed investors
What’s driving deals
- Value-based-care transition and risk adoption.
- Medicare Advantage and ACO growth.
- Data-and-analytics-driven consolidation.
Find Chronic Disease Management acquisition targets
Search Acquisera’s index for companies classified under Chronic Disease Management (4.4.9.3) and build a targeted deal pipeline.
Search companies